AI IntelligenceAug 24, 2026AI Intelligence
Article
The FDA cleared C2N Diagnostics' PrecivityAD2 blood test, developed from Washington University technology…
…to aid Alzheimer's diagnosis by detecting amyloid plaques. This marks a step toward accessible early detection.
AI-generated: summaries written by AI from the linked sources. How we use AI
AI-generatedSource: Hacker News
01
Source Brief
The FDA cleared C2N Diagnostics' PrecivityAD2 blood test, developed from Washington University technology, to aid Alzheimer's diagnosis by detecting amyloid plaques. This marks a step toward accessible early detection.
02